Award
National Cancer Institute 2P01CA163227-11A1
Androgen Receptor Action in Castration Resistant Prostate Cancer
Recipient
Not specified
Award Amount
$1,990,456.00
Ceiling
$1,990,456.00
Awarded
September 18, 2025
Identifier
2P01CA163227-11A1
Award for research on androgen receptor action in castration resistant prostate cancer funded by the National Cancer Institute under NIH grant PAR-23-059 with a budget of about $1.99 million for fiscal year 2025.
Description
The project focuses on the role of androgen receptor in prostate cancer, especially resistance mechanisms. The award is part of NIH grant PAR-23-059. The project involves multiple research projects and cores, including biospecimen and epigenetics cores. The funding is from the National Cancer Institute, with a total budget of approximately $1.99 million for the fiscal year 2025.